| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy
|
Jo, Tomoyasu
|
|
|
|
7 |
p. 365.e1-365.e7
|
artikel
|
| 2 |
A Clinical Review of the Different Strategies to Minimize Hemorrhagic Cystitis Associated with the Use of Post-Transplantation Cyclophosphamide in an Allogeneic Transplant
|
Ngo, Dat
|
|
|
|
7 |
p. 349-354
|
artikel
|
| 3 |
A Low Level of Plasmacytoid Dendritic Cells at Engraftment Is a Valuable Prognostic Indicator in Children Receiving Allogeneic Hematopoietic Stem Cell Transplantation
|
Li, Bohan
|
|
|
|
7 |
p. 611.e1-611.e12
|
artikel
|
| 4 |
American Society of Transplantation and Cellular Therapy International Affair Committee: Report of the Third Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting
|
Okamoto, Shinichiro
|
|
|
|
7 |
p. 410-417
|
artikel
|
| 5 |
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy
|
Gazeau, Nicolas
|
|
|
|
7 |
p. 430-437
|
artikel
|
| 6 |
An Algorithm Addressing the Problem of Overdiagnosis of Clostridioides difficile Infections in Hematopoietic Stem Cell Transplantation Recipients: Effects on C. difficile Infection Rates and Patient Outcomes
|
Ford, Clyde D.
|
|
|
|
7 |
p. 471.e1-471.e7
|
artikel
|
| 7 |
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-Disease
|
Patel, Sagar S.
|
|
|
|
7 |
p. 465.e1-465.e7
|
artikel
|
| 8 |
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis
|
Smith, Elliot
|
|
|
|
7 |
p. 600.e1-600.e8
|
artikel
|
| 9 |
ASTCT Notes
|
|
|
|
|
7 |
p. 623
|
artikel
|
| 10 |
ASTCT Notes
|
|
|
|
|
7 |
p. 412
|
artikel
|
| 11 |
Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults
|
Mishra, Asmita
|
|
|
|
7 |
p. 617.e1-617.e7
|
artikel
|
| 12 |
Caring for Our Patients, Their Loved Ones and Each Other
|
Sullivan, Keith M.
|
|
|
|
7 |
p. 404-405
|
artikel
|
| 13 |
Cell-Free DNA Dynamic Concentration and Other Variables Are Predictors of Early Progression after Chimeric Antigen Receptor T Cell Therapy in Patients with Diffuse Large B Cell Lymphoma
|
Bastos-Oreiro, Mariana
|
|
|
|
7 |
p. 472.e1-472.e4
|
artikel
|
| 14 |
Cellular Immunotherapy—Highlights from TCT 2021
|
Reshef, Ran
|
|
|
|
7 |
p. 527-532
|
artikel
|
| 15 |
Change in Patients’ Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
|
Barata, Anna
|
|
|
|
7 |
p. 401.e1-401.e7
|
artikel
|
| 16 |
Chimeric Antigen Receptor T Cell Therapy: A Comprehensive Review of Clinical Efficacy, Toxicity, and Best Practices for Outpatient Administration
|
Alexander, Maurice
|
|
|
|
7 |
p. 558-570
|
artikel
|
| 17 |
Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation
|
Vergara-Cadavid, Juliana
|
|
|
|
7 |
p. 455.e1-455.e9
|
artikel
|
| 18 |
Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample—The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study
|
Wauben, B.
|
|
|
|
7 |
p. 468.e1-468.e8
|
artikel
|
| 19 |
Combining Three Different Pretransplantation Scores Improves Predictive Value in Patients after Haploidentical Stem Cell Transplantation with Thiotepa, Busulfan, and Fludarabine Conditioning and Post-Transplantation Cyclophosphamide
|
Esquirol, Albert
|
|
|
|
7 |
p. 614.e1-614.e8
|
artikel
|
| 20 |
Comparison of Patient and Provider Practices between Bone Marrow and Solid Organ Transplantation Programs for Patient Education on Increased Risk of Skin Cancer
|
Shope, Chelsea
|
|
|
|
7 |
p. 466.e1-466.e7
|
artikel
|
| 21 |
Comparisons of Modified Post-Transplantation Cyclophosphamide and Granulocyte Colony-Stimulating Factor/Antithymocyte Globulin Regimens for Haploidentical Stem Cell Transplantation in Patients with Aplastic Anemia
|
Li, Yun
|
|
|
|
7 |
p. 396.e1-396.e9
|
artikel
|
| 22 |
Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients
|
Domingo, Walter
|
|
|
|
7 |
p. 622.e1-622.e5
|
artikel
|
| 23 |
Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101
|
Ramsey, Scott D.
|
|
|
|
7 |
p. 464.e1-464.e8
|
artikel
|
| 24 |
COVID-19 and Hematopoietic Cell Transplantation Center-Specific Survival Analysis: Can We Adjust for the Impact of the Pandemic? Recommendations of the COVID-19 Task Force of the 2020 Center for International Blood and Marrow Transplantation Research Center Outcomes Forum
|
Wingard, John R.
|
|
|
|
7 |
p. 533-539
|
artikel
|
| 25 |
Cyclosporine A regulates PMN-MDSCs viability and function through MPTP in acute GVHD: Old medication, new target
|
Li, Xiaoqing
|
|
|
|
7 |
p. 411.e1-411.e9
|
artikel
|
| 26 |
Dawn of Hope for Improved Access to BCMA Therapy: Chimeric Antigen Receptor T Cell and Bispecific Products
|
Ahmed, Nausheen
|
|
|
|
7 |
p. 474-475
|
artikel
|
| 27 |
Deciphering the role of Minor histocompatibility antigens for acute graft-versus-host disease
|
Giesler, Sophie
|
|
|
|
7 |
p. 523-524
|
artikel
|
| 28 |
Editorial Board
|
|
|
|
|
7 |
p. A7
|
artikel
|
| 29 |
Editorial Board
|
|
|
|
|
7 |
p. A10
|
artikel
|
| 30 |
Editorial Board
|
|
|
|
|
7 |
p. A7
|
artikel
|
| 31 |
Effect of Multiple HLA Locus Mismatches on Outcomes after Single Cord Blood Transplantation
|
Kanda, Junya
|
|
|
|
7 |
p. 398.e1-398.e9
|
artikel
|
| 32 |
Endothelial Activation and Stress Index-Measured Pretransplantation Predicts Transplantation-Related Mortality in Patients with Thalassemia Major Undergoing Transplantation with Thiotepa, Treosulfan, and Fludarabine Conditioning
|
Kulkarni, Uday P.
|
|
|
|
7 |
p. 356.e1-356.e6
|
artikel
|
| 33 |
Evaluation of the Pharmacokinetic Interaction Between Letermovir and Tacrolimus in Allogeneic Hematopoietic Cell Transplantation Recipients
|
Marciano, Kelsey A.
|
|
|
|
7 |
p. 371.e1-371.e4
|
artikel
|
| 34 |
Feasibility and Efficacy of Partially Replacing Post-Transplantation Cyclophosphamide with Bendamustine in Pediatric and Young Adult Patients Undergoing Haploidentical Bone Marrow Transplantation
|
Katsanis, Emmanuel
|
|
|
|
7 |
p. 390.e1-390.e10
|
artikel
|
| 35 |
FLT3-ITD Allelic Ratio and NPM1 Mutation Do Not Impact Outcomes in Acute Myeloid Leukemia Patients with FLT3-ITD after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Propensity Score- Matching Study
|
Zhou, Cuiyan
|
|
|
|
7 |
p. 456.e1-456.e11
|
artikel
|
| 36 |
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive Therapy
|
Roll, Wolfgang
|
|
|
|
7 |
p. 603-610
|
artikel
|
| 37 |
Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation
|
Story, Charlotte McIlwaine
|
|
|
|
7 |
p. 591-599
|
artikel
|
| 38 |
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Bendamustine in Patients with Refractory Acute Leukemia: A Dose-Ranging Study
|
Moiseev, Ivan
|
|
|
|
7 |
p. 601.e1-601.e7
|
artikel
|
| 39 |
Guidelines for the Prevention and Management of Graft-versus-Host Disease after Cord Blood Transplantation
|
Ponce, Doris M.
|
|
|
|
7 |
p. 540-544
|
artikel
|
| 40 |
Haploidentical Stem Cell Transplantation After TCR-αβ+ and CD19+ Cells Depletion In Children With Congenital Non-Malignant Disease
|
Giardino, Stefano
|
|
|
|
7 |
p. 394.e1-394.e9
|
artikel
|
| 41 |
Haploidentical versus Matched Unrelated versus Matched Sibling Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
|
Mehta, Rohtesh S.
|
|
|
|
7 |
p. 395.e1-395.e11
|
artikel
|
| 42 |
Health Care Resource Utilization and Total Costs of Care Among Patients with Diffuse Large B Cell Lymphoma Treated with Chimeric Antigen Receptor T Cell Therapy in the United States
|
Keating, Scott J.
|
|
|
|
7 |
p. 404.e1-404.e6
|
artikel
|
| 43 |
Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101
|
El Jurdi, Najla
|
|
|
|
7 |
p. 467.e1-467.e5
|
artikel
|
| 44 |
Hematopoietic Stem Cell Transplantation in T Cell and Natural Killer Cell Lymphomas: Update on Recent Advances
|
Boo, Yang Liang
|
|
|
|
7 |
p. 571-588
|
artikel
|
| 45 |
Hepatitis B Virus Vaccination after Allogeneic Hematopoietic Cell Transplantation Prevents Post-Transplantation Hepatitis B Virus Reactivation
|
Hammond, Sarah P.
|
|
|
|
7 |
p. 402.e1-402.e5
|
artikel
|
| 46 |
High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation
|
Pedraza, Alexandra
|
|
|
|
7 |
p. 619.e1-619.e8
|
artikel
|
| 47 |
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
|
Narayan, Rupa
|
|
|
|
7 |
p. 452.e1-452.e11
|
artikel
|
| 48 |
Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host Disease
|
Turner, Jane
|
|
|
|
7 |
p. 616.e1-616.e6
|
artikel
|
| 49 |
How to predict response to treatment and outcome in patients with gastro-intestinal acute GVHD; Can 18F-FDG-PET scanning help?
|
Shimoni, Avichai
|
|
|
|
7 |
p. 525-526
|
artikel
|
| 50 |
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
|
Hines, Melissa R.
|
|
|
|
7 |
p. 438.e1-438.e16
|
artikel
|
| 51 |
Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia
|
Jarisch, Andrea
|
|
|
|
7 |
p. 366.e1-366.e7
|
artikel
|
| 52 |
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012
|
Brunstein, Claudio G.
|
|
|
|
7 |
p. 406.e1-406.e6
|
artikel
|
| 53 |
Impact of Chronic Graft-versus-Host Disease on Patient Employment, Income, and Informal Caregiver Burden: Findings From the Living With Chronic GVHD Patient Survey
|
Yu, Jingbo
|
|
|
|
7 |
p. 470.e1-470.e9
|
artikel
|
| 54 |
Impact of Preemptive Use of Tocilizumab on Chimeric Antigen Receptor T Cell Outcomes in Non-Hodgkin Lymphoma
|
De Philippis, Chiara
|
|
|
|
7 |
p. 429.e1-429.e6
|
artikel
|
| 55 |
Impact of Risk Factors and Long Term Survival Analysis of Patients With Primary Refractory Hodgkin Lymphoma Who Underwent High Dose Chemotherapy and Autologous Stem Cell Transplant
|
Akhtar, Saad
|
|
|
|
7 |
p. 451.e1-451.e12
|
artikel
|
| 56 |
Impact of Serum Insulin-Like Growth Factor 1 on Hematopoietic Stem Cell Transplantation Outcome in Pediatric Cancer Patients
|
Betzmann, Deborah
|
|
|
|
7 |
p. 355.e1-355.e9
|
artikel
|
| 57 |
Impact of Total Body Irradiation-Based Myeloablative Conditioning Regimens in Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Systematic Review and Meta-Analysis
|
Khimani, Farhad
|
|
|
|
7 |
p. 620.e1-620.e9
|
artikel
|
| 58 |
It Takes a Village: The Importance of Social Support after Hematopoietic Stem Cell Transplantation, a Qualitative Study
|
Amonoo, Hermioni L.
|
|
|
|
7 |
p. 400.e1-400.e6
|
artikel
|
| 59 |
KIR2DS4 and Its Variant KIR1D in KIR-AA Genotype Donors Showed Differential Survival Impact in Patients with Lymphoid Disease after HLA-Matched Unrelated Hematopoietic Stem Cell Transplantation
|
Gowdavally, Sowmya
|
|
|
|
7 |
p. 457.e1-457.e10
|
artikel
|
| 60 |
Length of Stay and Health Care Utilization Among Pediatric Autologous Hematopoietic Cell Transplantation Recipients
|
Davis, Laurie
|
|
|
|
7 |
p. 613.e1-613.e7
|
artikel
|
| 61 |
Long-Term Follow-Up of Multiple Myeloma Patients Treated with Tandem Autologous Transplantation Following Melphalan and Upon Recovery, Total Marrow Irradiation
|
Ladbury, Colton
|
|
|
|
7 |
p. 367.e1-367.e9
|
artikel
|
| 62 |
Masthead (Purpose and Scope)
|
|
|
|
|
7 |
p. A6
|
artikel
|
| 63 |
Masthead (Purpose and Scope)
|
|
|
|
|
7 |
p. A9
|
artikel
|
| 64 |
Masthead (Purpose and Scope)
|
|
|
|
|
7 |
p. A6
|
artikel
|
| 65 |
Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma
|
Rejeski, Kai
|
|
|
|
7 |
p. 418-428
|
artikel
|
| 66 |
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
|
Kitko, Carrie L.
|
|
|
|
7 |
p. 545-557
|
artikel
|
| 67 |
Officers and Directors of ASTCT
|
|
|
|
|
7 |
p. A12
|
artikel
|
| 68 |
Officers and Directors of ASTCT
|
|
|
|
|
7 |
p. A12
|
artikel
|
| 69 |
Officers and Directors of ASTCT
|
|
|
|
|
7 |
p. A8
|
artikel
|
| 70 |
Optimizing Donor Chimerism Threshold for Next-Generation Sequencing Monitoring of Measurable Residual Disease Post-Allogeneic Stem Cell Transplantation for Myeloid Neoplasms
|
Puzo, Christian J.
|
|
|
|
7 |
p. 459.e1-459.e4
|
artikel
|
| 71 |
Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation
|
Karantoni, Eleni
|
|
|
|
7 |
p. 403.e1-403.e7
|
artikel
|
| 72 |
Overcoming Barriers to Referral for Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
|
Hoffmann, Marc S.
|
|
|
|
7 |
p. 440-448
|
artikel
|
| 73 |
Parent Psychological Distress Is Associated with Symptom Burden and Health-Related Quality of Life in Children and Adolescents Undergoing Stem Cell Transplantation or Chimeric Antigen Receptor T Cell Therapy
|
Ward, Jessica
|
|
|
|
7 |
p. 462.e1-462.e9
|
artikel
|
| 74 |
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin Lymphoma
|
Ahmed, Nausheen
|
|
|
|
7 |
p. 449.e1-449.e7
|
artikel
|
| 75 |
Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
|
Das, Tongted P.
|
|
|
|
7 |
p. 454.e1-454.e8
|
artikel
|
| 76 |
Post-Transplantation Day +100 Minimal Residual Disease Detection Rather Than Mixed Chimerism Predicts Relapses after Allogeneic Stem Cell Transplantation for Intermediate-Risk Acute Myelogenous Leukemia Patients Undergoing Transplantation in Complete Remission
|
Klyuchnikov, Evgeny
|
|
|
|
7 |
p. 374.e1-374.e9
|
artikel
|
| 77 |
Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era
|
Shimada, Hiroyuki
|
|
|
|
7 |
p. 376-389
|
artikel
|
| 78 |
Prospective Randomized Study of Advance Directives in Allogeneic Hematopoietic Cell Transplantation Recipients
|
Tan, Irena T.
|
|
|
|
7 |
p. 615.e1-615.e7
|
artikel
|
| 79 |
Prospective Study of a Modified Post-Transplantation Cyclophosphamide Regimen for Severe Aplastic Anemia Patients with HLA-Haploidentical Transplantation
|
Wu, Liangliang
|
|
|
|
7 |
p. 463.e1-463.e7
|
artikel
|
| 80 |
Race and Survival in Unrelated Hematopoietic Cell Transplantation
|
Morishima, Yasuo
|
|
|
|
7 |
p. 357.e1-357.e6
|
artikel
|
| 81 |
Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome after Hematopoietic Cell Transplantation
|
Saqr, Abdelrahman
|
|
|
|
7 |
p. 372.e1-372.e9
|
artikel
|
| 82 |
Reflections: A New Monthly Feature in Transplantation and Cellular Therapy
|
Sullivan, Keith M.
|
|
|
|
7 |
p. 403
|
artikel
|
| 83 |
Rush Hour Update: Roadblocks to CARs on the Expressway
|
Sauter, Craig S.
|
|
|
|
7 |
p. 408-409
|
artikel
|
| 84 |
Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis
|
Muchtar, Eli
|
|
|
|
7 |
p. 589.e1-589.e6
|
artikel
|
| 85 |
Socioeconomic and Racial Disparity in Chimeric antigen receptor T cell (CART)Therapy Access
|
Blue, Brandon
|
|
|
|
7 |
p. 345-346
|
artikel
|
| 86 |
Socioeconomic and Racial Disparity in Chimeric Antigen Receptor T Cell Therapy Access
|
Ahmed, Nausheen
|
|
|
|
7 |
p. 358-364
|
artikel
|
| 87 |
Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era
|
Johnsrud, Andrew
|
|
|
|
7 |
p. 590.e1-590.e8
|
artikel
|
| 88 |
Successful Outcome in Patients with Myelofibrosis Undergoing Allogeneic Donor Hematopoietic Cell Transplantation Using Reduced Doses of Post-Transplantation Cyclophosphamide: Challenges and Review of the Literature
|
García-Cadenas, Irene
|
|
|
|
7 |
p. 473.e1-473.e6
|
artikel
|
| 89 |
Superior Graft-versus-Host Disease-Free Relapse-Free Survival in Matched Unrelated Donor Hematopoietic Stem Cell Transplantation with Anti-Thymocyte Globulin (ATG) Compared to Matched Related Donor without ATG
|
Remberger, Mats
|
|
|
|
7 |
p. 621.e1-621.e3
|
artikel
|
| 90 |
Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure
|
Candeliere, Jasmine
|
|
|
|
7 |
p. 408.e1-408.e8
|
artikel
|
| 91 |
Table of Contents
|
|
|
|
|
7 |
p. A15-A18
|
artikel
|
| 92 |
Table of Contents
|
|
|
|
|
7 |
p. A13-A17
|
artikel
|
| 93 |
Table of Contents
|
|
|
|
|
7 |
p. A9-A13
|
artikel
|
| 94 |
Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation
|
Ali, Naveed
|
|
|
|
7 |
p. 370.e1-370.e10
|
artikel
|
| 95 |
Thinking Clearly with Anakinra
|
Frey, Noelle V.
|
|
|
|
7 |
p. 406-407
|
artikel
|
| 96 |
Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in Remission
|
Stein, Anthony S.
|
|
|
|
7 |
p. 368.e1-368.e7
|
artikel
|
| 97 |
Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?
|
Jodele, Sonata
|
|
|
|
7 |
p. 392.e1-392.e9
|
artikel
|
| 98 |
Transplantation Referral Patterns for Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia at Academic and Community Sites in the Connect® Myeloid Disease Registry: Potential Barriers to Care
|
Tomlinson, Benjamin
|
|
|
|
7 |
p. 460.e1-460.e9
|
artikel
|
| 99 |
UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities
|
Dumont-Lagacé, Maude
|
|
|
|
7 |
p. 410.e1-410.e5
|
artikel
|
| 100 |
Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes
|
Phelan, Rachel
|
|
|
|
7 |
p. 409.e1-409.e10
|
artikel
|
| 101 |
When should a Reduced intensity Conditioning (RIC) Hematopoietic Stem Cell Transplant (HSCT) be Considered in Pediatric CML-CP1?
|
Chaudhury, Sonali
|
|
|
|
7 |
p. 347-348
|
artikel
|
Tijdschrift beschrijving